Treat CF as Deeply as You Live. Treat the cause with ORKAMBI®.
ORKAMBI is a breakthrough treatment for the underlying cause of cystic fibrosis (CF) in people with 2 copies of the F508del mutation. And that's pretty exciting.
ORKAMBI is a prescription medicine used for the treatment of cystic fibrosis (CF) in patients age 12 years and older who have two copies of the F508del mutation (F508del/F508del) in their CFTR gene.
ORKAMBI should not be used in patients other than those who have two copies of the F508del mutation in their CFTR gene.
Watch ORKAMBI in action
Watch a video to learn about ORKAMBI, CFTR proteins, and the F508del mutation.